Please assess the completion status of the following clinical trial:

Trial Title: Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Reproductive-age women (age 18-45) with dysmenorrhea~* Average menstrual pain ≥ 5/10 (0=no pain and 10=the worst imaginable pain) on at least one day during menses or during withdrawal uterine bleeding from cyclic OCs without painkillers~* Menstrual pain in the region between the umbilicus and the perineum, above the level of the inguinal ligament~* Indication the participant has attempted to resolve pain by medical means (including NSAIDs and/or OCPs)~Exclusion Criteria:~* Presence of active pelvic or abdominal malignancies (primary or metastatic)~* Absence of regular menses (including current pregnancy, recent pregnancy, or active breast feeding)~* Active genitourinary infection in the last four weeks~* Unable to read or comprehend the informed consent in English~* Unwilling to complete study procedures~* Presence of hypertension or risk for developing hypertension~* Unwillingness to take naproxen and/or placebo~* Contradictions to taking naproxen (allergies, kidney disease, anemia, alcoholism, cardiovascular disease, stomach or intestinal ulcer or abnormal liver function)~* Formal urological diagnosis such as overactive bladder or bladder pain syndrome.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Primary Dysmenorrhea (Type: EXPERIMENTAL): We will look at the effects of naproxen 500mg use on pain starting just before and during menses.

Based on this trial design, predict the completion outcome and termination type (if applicable).